Skip to main content

Advertisement

SpringerLink
Log in

Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hall C, Krishnamurthy S, Lodhi A, et al. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010. doi:10.1245/s10434-010-1160-7.

  2. Listrom MB, and Dalton LW. Comparison of keratin monoclonal antibodies MAK-6, AE1: AE3 and CAM5.2. Am J Clin Pathol. 1987;88(3):297–300.

    PubMed  CAS  Google Scholar 

  3. Aden C, Reynold SC, Adlakha H, et al. Wide spectrum screening keratins as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients. Histopathology. 2002;40(6):556–62.

    Article  Google Scholar 

  4. Namikawa T, Kobayashi M, Iwabu J, et al. Primary undifferentiated carcinoma of small intestine: an immunohistochemical study and review of the literature. Med Mol Morphol. 2010;42(2):91–5.

    Article  Google Scholar 

  5. Tamas EF, Epstein JI. Detection of residual tumor cells in bladder biopsy specimen: pitfalls in the interpretation of cytokeratin stain. Am J Surg Pathol. 2007;31(3):390–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Savitri Krishnamurthy MD

  2. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Anthony Lucci MD

Authors
  1. Savitri Krishnamurthy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Lucci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Lucci MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnamurthy, S., Lucci, A. Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients. Ann Surg Oncol 18 (Suppl 3), 263–264 (2011). https://doi.org/10.1245/s10434-010-1421-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1421-5

Keywords

Search

Navigation